In contrast, other models demonstrated that ablation of Nrf2 reduced aggressive tumor formation and upregulated tumor suppressors such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), suggesting that in later stages Nrf2 may facilitate tumor growth [89,205]. Here, NFE2L2 is linked to neoplasm.